40th Sysmex Scientific Seminar (Japan); Diagnosis of Haematological Disease and Further Advance: The Front-Line and Foresight to the Future

Semi-automated coagulation analyser

The milestone 40th Sysmex Scientific Seminar was held under the title of “Diagnosis of Haematological Disease and Further Advance: The Front-Line and Future Prospects”, offering a transversal overview of developments in the examination and treatment of hematologic diseases. Japan’s top-level researchers have lectured on subjects that are representative of wide-ranging segments of haematology, presenting the front line of examination and treatment in this domain, based on the most recent research achievements, and exploring future prospects.

Videos

Disclaimer – The videos will be sent only by request.

Placeholder

1. Recent advance in the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria (PNH)

Read more

1. Recent advance in the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria (PNH)

Read more
Discussion on the recent progress in the pathogenesis, diagnosis and treatment of Paroxysmal nocturnal hemoglobinuria (PNH).
Professor Yuzuru KANAKURA, M.D., Ph.D. The Department of Hematology and Oncology, Osaka University Graduate School of Medicine
products_default

2. Understanding of genetic alterations in myeloproliferative neoplasms

Read more

2. Understanding of genetic alterations in myeloproliferative neoplasms

Read more
Introduction of a research findings of JAK2V617F, CALR, and MPL mutations in patients suspected of Philadelphia-negative myeloproliferative neoplasm (MPN), as well as discussion on surrounding issues.
Professor Norio KOMATSU, M.D., Ph.D. Department of Hematology, Juntendo University School of Medicine
Placeholder

3. On the genetic basis of myelodysplastic syndromes

Read more

3. On the genetic basis of myelodysplastic syndromes

Read more
Summary of major advances of recent years in the field of MDS research, focusing on the results of the studies by Prof. Ogawa’s team.
Professor Seishi OGAWA, M.D., Ph.D.,Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University
products_default

4. Antithrombin resistance: a new mechanism of inherited thrombophilia

Read more

4. Antithrombin resistance: a new mechanism of inherited thrombophilia

Read more
Introduction of a study investigating a possible causative gene defect in the large Japanese family with inherited thrombophilia, as well as the discovery of a novel missense mutation in the prothombin gene (p.ARG596Leu) resulting in a variant prothrombin.
Professor Tetsuhito KOJIMA, M.D., Ph, D.Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine
Placeholder

5. Progress and vision in the treatment of hemophilia

Read more

5. Progress and vision in the treatment of hemophilia

Read more
An overview of the recent progress and vision in the treatment of hemophilia including clinical trials on therapeutic drugs and gene therapy.
Professor Midori SHIMA, M.D., Ph, D.Department of Pediatrics, Nara Medical University